Karrie Spath Hilsinger

Karrie Spath Hilsinger has extensive experience in clinical operations, holding leadership positions such as Head of Clinical Operations at UroGen Pharma, SPARK Neuro, and Priovant Therapeutics. Additionally, Karrie served as Senior Director of Clinical Operations at Epizyme and as Clinical Program Study Director at Immunomedics. Karrie Spath Hilsinger earned a degree from Kean University between 1992 and 1997.